Literature DB >> 19578343

Management of new-onset epilepsy in the elderly.

Amir M Arain1, Bassel W Abou-Khalil.   

Abstract

The incidence of new-onset epilepsy is high among elderly patients. Seizures can present differently to and with more subtle semiology than those in younger adults. This difference in presentation frequently poses a diagnostic challenge. Elderly patients also often have comorbidities, are usually on multiple medications that can interact, have altered medication pharmacokinetics, and tend to be particularly sensitive to adverse effects of medication. Seizures in the elderly tend, however, to respond better to antiepileptic drugs than those in younger individuals, and can often be appropriately controlled with monotherapy. After the diagnosis of epilepsy is confirmed, treatment should be started with a single medication at a low dose, with subsequent gradual upward titration until seizures are controlled. First-generation antiepileptic drugs should be avoided in the elderly in view of poor tolerability. A large trial has shown that lamotrigine and gabapentin are better tolerated than carbamazepine. In elderly patients whose seizures remain uncontrolled on antiepileptic medications, surgery can be considered if excellent results are predicted and the risks are low.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578343     DOI: 10.1038/nrneurol.2009.74

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  87 in total

1.  Epilepsy surgery after age 60.

Authors:  Indrani Acosta; Fernando Vale; William O Tatum; Selim R Benbadis
Journal:  Epilepsy Behav       Date:  2007-11-26       Impact factor: 2.937

2.  Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.

Authors:  D Blum; K Meador; V Biton; T Fakhoury; B Shneker; S Chung; K Mills; A Hammer; J Isojärvi
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Warfarin and phenytoin interaction.

Authors:  J M Nappi
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

4.  Use of antiepileptic medications in nursing homes.

Authors:  Judith Garrard; Susan L Harms; Lynn E Eberly; Ilo E Leppik
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 5.  What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases.

Authors:  Peggy Quinette; Bérengère Guillery-Girard; Jacques Dayan; Vincent de la Sayette; Sophie Marquis; Fausto Viader; Béatrice Desgranges; Francis Eustache
Journal:  Brain       Date:  2006-05-02       Impact factor: 13.501

6.  Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.

Authors:  Scott Mintzer; Christopher T Skidmore; Caitlin J Abidin; Megan C Morales; Inna Chervoneva; David M Capuzzi; Michael R Sperling
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Pharmacokinetics of valproic acid in the elderly.

Authors:  E Perucca; R Grimaldi; G Gatti; S Pirracchio; F Crema; G M Frigo
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

8.  Non-epileptic seizures of the elderly.

Authors:  Christoph Kellinghaus; Tobias Loddenkemper; Dudley S Dinner; Deepak Lachhwani; Hans O Lüders
Journal:  J Neurol       Date:  2004-06       Impact factor: 4.849

9.  Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia.

Authors:  T Lempert; M Bauer; D Schmidt
Journal:  Ann Neurol       Date:  1994-08       Impact factor: 10.422

10.  Reversible parkinsonism and cognitive impairment with chronic valproate use.

Authors:  C Armon; C Shin; P Miller; S Carwile; E Brown; J D Edinger; R G Paul
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  8 in total

Review 1.  New-onset epilepsy in the elderly.

Authors:  Lily Chi Vu; Loretta Piccenna; Patrick Kwan; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2018-07-28       Impact factor: 4.335

2.  Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment.

Authors:  Aida Rodriguez-Sainz; Ana Pinedo-Brochado; Jose L Sánchez-Menoyo; Javier Ruiz-Ojeda; Ines Escalza-Cortina; Juan Carlos Garcia-Monco
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06

3.  Defining incident cases of epilepsy in administrative data.

Authors:  Paul M Bakaki; Siran M Koroukian; Leila W Jackson; Jeffrey M Albert; Kitti Kaiboriboon
Journal:  Epilepsy Res       Date:  2013-06-20       Impact factor: 3.045

4.  Factors predicting neuronal surface antibodies in the elderly with new-onset and unknown seizures.

Authors:  Xiao Liu; Tingting Yu; Jing Qi; Ruijuan Lv; Qun Wang
Journal:  Ann Clin Transl Neurol       Date:  2022-05-22       Impact factor: 5.430

5.  Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

Authors:  E Turpin; A Muscat; C Vatier; G Chetrite; E Corruble; M Moldes; B Fève
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

6.  Prevalence and Incidence of Epilepsy in an Elderly and Low-Income Population in the United States.

Authors:  Derek H Tang; Daniel C Malone; Terri L Warholak; Jenny Chong; Edward P Armstrong; Marion K Slack; Chiu Hsieh Hsu; David M Labiner
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

Review 7.  Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.

Authors:  Junji Saruwatari; Takateru Ishitsu; Kazuko Nakagawa
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-20

8.  Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.

Authors:  Bernd Pohlmann-Eden; Anthony G Marson; Matthias Noack-Rink; Francisco Ramirez; Azita Tofighy; Konrad J Werhahn; Imane Wild; Eugen Trinka
Journal:  BMC Neurol       Date:  2016-08-23       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.